







Recreational sandboxes for children and dogs can be a 
source of epidemic ribotypes of Clostridium dificile 
 
 
Journal: Zoonoses and Public Health 
Manuscript ID ZPH-Jan-17-035.R1 
Manuscript Type: Original Article 
Date Submitted by the Author: n/a 
Complete List of Authors: Orden, Cristina; FACULTAD DE VETERINARIA. UNIVERSIDAD 
COMPLUTENSE, SANIDAD ANIMAL 
Neila, Carlos; FACULTAD DE VETERINARIA. UNIVERSIDAD COMPLUTENSE, 
SANIDAD ANIMAL 
BLANCO, JOSE; FACULTAD DE VETERINARIA. UNIVERSIDAD 
COMPLUTENSE, SANIDAD ANIMAL 
ALVAREZ-PEREZ, SERGIO; FACULTAD DE VETERINARIA. UNIVERSIDAD 
COMPLUTENSE, SANIDAD ANIMAL 
Harmanus, Céline; Leiden University Medical Center 
Kuijper, Ed; Leiden, Medicine Microbiology 
GARCIA, MARTA; Universidad Complutense de Madrid, ANIMAL HEALTH 









Original Article 1 
 2 
Recreational sandboxes for children and dogs can be a source of 3 
epidemic ribotypes of Clostridium dificile 4 
 5 
Cristina Orden1, Carlos Neila1, José L. Blanco1, Sergio Álvarez-Pérez1, Celine 6 
Harmanus2, Ed J. Kuijper2, and Marta E. García1 7 
 8 
Short title: C. difficile in sandboxes  9 
 10 
Authors and affiliations 11 
1
 Department of Animal Health, Faculty of Veterinary, Universidad Complutense de 12 
Madrid, Madrid, Spain 13 
2
 Department of Medical Microbiology, Center of Infectious Diseases, Leiden University 14 
Medical Center, Leiden, Netherlands 15 
 16 
Correspondence: 17 
Prof. José L. Blanco, PhD, DVM. Departamento de Sanidad Animal, Facultad de 18 
Veterinaria, Universidad Complutense de Madrid. Avda. Puerta de Hierro s/n, 28040 19 
Madrid (Spain). Tel.: +34 91 394 3717. E-mail address: jlblanco@ucm.es20 
Page 1 of 50

































































 Impacts 21 
• The sand of public playgrounds can have a role in the transmission of various 22 
infections, particularly in children. 23 
• In this study we demonstrated that the Gram-positive anaerobe Clostridium difficile is 24 
widely distributed in soils samples from children’s and dog’s sandboxes located within 25 
the metropolitanean area of Madrid. 26 
• Furthermore, we demonstrated the presence of genetically diverse strains of C. difficile, 27 
including the epidemic PCR ribotypes 014 and 106, in the studied sandboxes. 28 
29 
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Different studies have suggested that the sand of public playgrounds could have a role in 31 
the transmission of infections, particularly in children. Furthermore, free access of pets and 32 
other animals to the playgrounds might increase such a risk. We studied the presence of 33 
Clostridium difficile in 20 pairs of sandboxes for children and dogs located in different 34 
playgrounds within the Madrid region (Spain). C. difficile isolation was performed by 35 
enrichment and selective culture procedures. The genetic (ribotype and amplified fragment 36 
length polymorphism [AFLP]) diversity and antibiotic susceptibility of isolates was also 37 
studied. Overall, 52.5% (21/40) of samples were positive for the presence of C. difficile. 38 
Eight of the 20 available isolates belonged to the toxigenic ribotypes 014 (n = 5) and 106 (n 39 
= 2), both regarded as epidemic, and CD047 (n = 1). The other 12 isolates were non-40 
toxigenic, and belonged to ribotypes 009 (n = 5), 039 (n = 4), and 067, 151 and CD048 41 
(one isolate each). Nevertheless, all isolates (even those of a same ribotype) were classified 42 
into different AFLP genotypes indicating non-relatedness. In conclusion, our results 43 
revealed the presence of epidemic ribotypes of C. difficile in children’s and dog’s 44 
sandboxes located nearby, which constitutes a major health risk. 45 
 46 
Keywords: Clostridium difficile; children; dog; epidemic strains; sandboxes. 47 
48 
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The soil of playgrounds is a reservoir of diverse parasites and infectious agents (Martínez-50 
Moreno et al., 2007; Dado et al., 2012; Gotkowska-Płachta and Korzeniewska, 2014; Staley 51 
et al., 2016). Furthermore, free access of domestic and wild animals to recreational areas 52 
can increase the burden of microbiological contamination (Haag-Wackernagel and Moch, 53 
2004; Martínez-Moreno et al., 2007; Dado et al., 2012; Gotkowska-Płachta and 54 
Korzeniewska, 2014; Staley et al., 2016). Children are generally regarded as the main 55 
group at risk for environmental exposure to pathogens, not only because they are frequent 56 
users of playgrounds, but also due to the high prevalence of geophagia (i.e. consumption of 57 
sand) within this group, and the immaturity of their immunological, neurological and 58 
digestive systems (Nwachuku and Gerba, 2004; Dado et al., 2012; Gotkowska-Płachta and 59 
Korzeniewska, 2014). 60 
Clostridium difficile is a Gram-positive, anaerobic bacterium of widespread 61 
distribution in the environment, where it can survive under adverse conditions through the 62 
production of spores (Hensgens et al., 2012; Smits et al., 2016). This bacterial species was 63 
traditionally regarded as a primarily nosocomial pathogen, but this view has been 64 
challenged as the incidence of C. difficile infection (CDI) in people outside hospitals started 65 
to increase (Hensgens et al., 2012; Smits et al., 2016). In this context, diverse animal 66 
species, food products and environmental sources have been suggested to play a role in the 67 
transmission of the C. difficile and, in particular, of some epidemic genotypes such as 68 
ribotype 078 (Hensgens et al., 2012; Smits et al., 2016). However, to the best of our 69 
knowledge, the presence of C. difficile in sandboxes of playgrounds has only been explored 70 
in a limited number of studies (al Saif and Brazier, 1996; Higazi et al. 2011; Båverud et al., 71 
2003). 72 
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In this study we determined the presence of C. difficile in 20 pairs of recreational 73 
sandboxes for children and dogs located in different playgrounds within the Madrid region 74 
(Spain). In addition, we compared the isolates recovered from children’s and dog’s 75 
sandboxes in terms of genetic characteristics and in vitro antimicrobial susceptibility. 76 
 77 
Materials and methods 78 
Sampling scheme 79 
Sampling was carried out on two consecutive days (July 1-2, 2015) in 20 pairs of children’s 80 
and dog’s sandboxes located nearby (within 94 m in all cases, mean ± S.D. = 35.1 ± 20.5 81 
m; Table 1) in public playgrounds scattered throughout three zones (A, M and V; postal 82 
codes: E-28047, E-28222/E-28221/E-28220 and E-28400, respectively) within the Madrid 83 
region (central Spain) (Figure S1). Therefore, a total of 40 sandboxes (20 for children and 84 
20 for dogs) were analyzed. The number and distribution of samples per sampling zone and 85 
sampling point is indicated in Table 1. 86 
A 200-g sand sample was obtained from each sampling point according to the 87 
procedure described in Córdoba et al. (2002). Briefly, four 50-g sand samples were 88 
collected from different locations within the sampling point using a sterile plastic container 89 
(Nirco, Madrid, Spain). All four sand samples were then thoroughly mixed in a sterile 90 
plastic bag (Nirco), which was transported to the laboratory and kept frozen (-20ºC) until 91 
analyzed. 92 
93 
Page 5 of 50

































































Microbiological analyses 94 
Sand samples (50 g each, taken and aseptically weighted from the 200-g mixtures kept in 95 
the freezer) were transferred into sterile one-liter glass bottles, diluted 1:10 in peptone 96 
water (Laboratorios Conda, Madrid. Spain) and incubated under agitation (200 rpm) for 15 97 
min at room temperature. These suspensions were then allowed to settle for 5 min and the 98 
supernatants were filtered though filter membranes (0.45 µm of pore size; Filter Lab, 99 
Barcelona, Spain) following the procedure detailed in Álvarez-Pérez et al. (2016). Filter 100 
membranes were then introduced into 10-ml glass tubes containing 5 ml of selective broth 101 
for enrichment of C. difficile (TecLaim, Madrid, Spain; see recipe in Blanco et al., 2013). 102 
After seven days of incubation at 37°C under anaerobiosis, 2 ml of the enrichment culture 103 
were mixed 1:1 with absolute ethanol (Panreac, Barcelona, Spain) in 5 ml sterile plastic 104 
tubes (Nirco) and left for 1 hour under agitation (200 rpm) at room temperature. Finally, 105 
tubes were centrifuged at 1520 g for 10 min, the supernatants were discarded and 106 
precipitates were spread with a sterile cotton-tipped swab (Nirco) onto a plate of CLO agar 107 
(bioMérieux, Marcy l’Etoile, France), which contains cycloserine and cefoxitin as selective 108 
agents. Inoculated plates were incubated under anaerobic conditions for 72 h at 37°C and 109 
suspected colonies were identified as C. difficile by colony morphology, the typical odor of 110 
this microorganism, and a positive result in a rapid specific immunoassay for detection of 111 
the constitutive antigen glutamate dehydrogenase (GDH) (C. Diff Quik Chek Complete; 112 
TECHLAB Inc., Blacksburg, VA, USA). The same immunoassay was used to determine 113 
the toxigenic/non toxigenic status of isolates, as it detects production of C. difficile toxins A 114 
and B. A single C. difficile isolate was selected from each primary culture and sub-cultured 115 
on CLO agar to obtain axenic cultures that could be used in subsequent tests. 116 
 117 
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Molecular characterization of isolates 118 
Possession of tcdA and tcdB genes (which encode for toxins A and B, respectively), and 119 
cdtA and cdtB (which encode for the two components of binary toxin (CDT), respectively), 120 
was analyzed by conventional PCR protocols (Álvarez-Pérez et al. 2009, 2014, 2015). 121 
Genotyping of isolates was performed by high-resolution capillary gel-based 122 
electrophoresis PCR-ribotyping, following the procedures described in Fawley et al. 123 
(2015). Ribotypes were designated according to the nomenclature of the Leiden (Prof. Ed 124 
Kuijper; The Netherlands)-Leeds (Dr. Warren Fawley and Prof. Mark Wilcox; UK) 125 
database. Novel ribotypes were named using internal reference codes (prefix ‘CD’ followed 126 
by a number). 127 
Isolates were further genetically characterized by amplified fragment length 128 
polynorphism (AFLP) fingerprinting, using the protocol detailed in Álvarez-Pérez et al. 129 
(2017). A binary 0/1 matrix was created based on the absence/presence of AFLP markers 130 
and a dendrogram of AFLP patterns was created with PAST v.3.11 software (Hammer et 131 
al., 2001) using Pearson’s correlation coefficients and the unweighted-pair group method 132 
with arithmetic averages (UPGMA) clustering algorithm. Isolates clustering with <86% 133 
similarity were considered to represent different AFLP genotypes (Killgore et al., 2008; 134 
Álvarez-Pérez et al., 2017). 135 
 136 
Antimicrobial susceptibility testing 137 
In vitro susceptibility of isolates was determined by the Etest (bioMérieux) on prereduced 138 
Brucella agar supplemented with vitamin K1 and haemin (bioMérieux), according to the 139 
manufacturer’s instructions. Plates were incubated anaerobically at 37°C and examined at 140 
48 h. Tested antimicrobial compounds and breakpoints for antimicrobial resistance were as 141 
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follows: penicillin G, ≥2 µg/ml; teicoplanin, >2 µg/ml; rifampicin, ≥4 µg/ml; linezolid and 142 
tigecycline, >4 µg/ml; clindamycin, erythromycin and levofloxacin, ≥8 µg/ml; imipenem, 143 
minocycline and tetracycline, ≥16 µg/ml; amoxicillin/clavulanic acid, ≥16/8 µg/ml; and 144 
metronidazole and vancomycin, ≥32 µg/ml. (CLSI, 2012; Álvarez-Pérez et al., 2013, 2014, 145 
2015, 2017; Peláez et al. 2013). 146 
In order to detect possible metronidazole heteroresistance, which is manifested as a 147 
slow growth of resistant subpopulations within the inhibition halo in the Etest at 148 
concentrations above the resistance breakpoint, metronidazole test plates were further 149 
incubated anaerobically at 37°C for five additional days (Peláez et al., 2008). 150 
 151 
Data analysis 152 
Fisher’s exact test and Pearson’s chi-square test were used for statistical analysis of 153 
categorical data where appropriate. P-values of <0.05 were considered to be statistically 154 
significant in all cases. 155 
 156 
Results 157 
Clostridium difficile was recovered from 21 (52.5%) of the sand samples analyzed, 158 
collected from 12 and 9 sandboxes located in recreational areas for dogs and children, 159 
respectively (Table 1). The distribution of isolates by sampling (sub)zone and type of 160 
sample (children’s or dog’s sandboxes) is shown in Table 1. There was no difference in C. 161 
difficile prevalence between children’s and dog’s sandboxes (P = 0.527) or among 162 
sampling zones (P = 0.203). A positive culture result for both samples of each pair was 163 
obtained in five cases, whereas C. difficile was recovered only from one sandbox of the pair 164 
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in 11 cases (four from children’s sandboxes and seven from dog’s sandboxes) and a 165 
negative culture result for both samples was obtained in four cases (Table 1). 166 
One C. difficile isolate (obtained from a children’s sandbox in zone A [sample A-N-167 
2], Table 1) was lost during subculturing in the laboratory. Eight of the 20 remaining 168 
isolates (six from dog’s and two from children’s sandboxes) were toxigenic and belonged 169 
to ribotypes 014 (A+B+CDT-, n = 5), 106 (A+B+CDT-, n = 2) and CD047 (isolate M-P-4, 170 
A+B+CDT-) (Tables 1 and S1, Figure 1). The other 12 isolates were non-toxigenic (i.e. A-B-171 
CDT-) and belonged to ribotypes 009 (n = 5), 039 (n = 4), and 067, 151 and CD048 (one 172 
isolate each) (Tables 1 and S1, Figure 1). Further genetic characterization of isolates by 173 
AFLP fingerprinting classified each one of these into a different genotype (Figure 1 and 174 
Table S1). Notably, clustering of isolates in the UPGMA dendrogram obtained from AFLP 175 
data was independent from the origin (both at the ‘(sub)zone’ and ‘children vs. dog areas’ 176 
levels) and ribotype of isolates (Figure 1). 177 
Regardless of their origin and genotype, all studied isolates showed resistance to 178 
imipenem and levofloxacin (Figure 1 and Table S1). Additionally, the isolates of ribotypes 179 
CD048 and 151 (A-N-8 and V-N-1, respectively) displayed resistance to clindamycin and 180 
erythromycin, and a ribotype 014 isolate (A-P-3) was resistant to penicillin (Figure 1 and 181 
Table S1). MICs to the other antimicrobial compound tested were generally low, and fell 182 
below the resistance breakpoint in all cases (Table S1). 183 
Notably, the samples obtained from a pair of children’s and dog’s sandboxes in zone 184 
V (V-N-2/V-P-2; Figure 2) yielded C. difficile isolates of a same toxigenic ribotype (014) 185 
and which showed a similar antimicrobial susceptibility profile, but the AFLP profiles of 186 
such isolates displayed limited similarity (Pearson’s correlation = 0.126) (Figure 1). In 187 
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contrast, four pairs of sand samples (A-N-3/A-P-3, A-N-4/A-P-4, A-N-5/A-P-5 and V-N-188 
1/V-P-1) yielded C. difficile isolates of different ribotypes. 189 
 190 
Discussion 191 
The growing number of pets and other animals leaving excrements in the sandboxes of 192 
playgrounds and other recreational areas constitute a serious epidemiological threat 193 
(Martínez-Moreno et al., 2007; Gotkowska-Płachta and Korzeniewska, 2014; Staley et al., 194 
2016). Current tests for assessing the sanitary conditions of sandboxes focus on detecting 195 
some select pathogenic parasites and bacterial indicators of fecal contamination (Martínez-196 
Moreno et al., 2007; Gotkowska-Płachta and Korzeniewska, 2014; Staley et al., 2016), but 197 
mostly neglect the possible presence of other emerging pathogens such as C. difficile. 198 
Reports of C. difficile presence in recreational sandboxes are still limited in number 199 
and of variable scope. For example, Al-Saif and Brazier (1996) reported the isolation of C. 200 
difficile from a 21% of soil samples taken from public parks, gardens, playgrounds and 201 
other locations in the suburbs of Cardiff, UK. Subsequent characterization of some of those 202 
soil isolates by PCR ribotyping and pyrolysis mass spectrometry (PyMS) fingerprinting 203 
revealed the presence of toxin-producers and different ribotypes (Al Saif et al., 1998). 204 
Similarly, Higazi et al. (2011) investigated by a PCR-based approach the presence of C. 205 
difficile in soil samples from public parks and elementary school playgrounds in a 206 
Midwestern town of the USA and reported an overall prevalence of 6.5%, but bacterial 207 
isolates were only obtained in some cases and these were not genotyped nor tested for 208 
antimicrobial resistance. Finally, Båverud et al. (2013) observed an overall C. difficile 209 
prevalence of 4% in soil samples obtained from public parks, playgrounds, gardens and 210 
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cultivated fields, but the origin and characteristics of recovered isolates were not detailed in 211 
their paper. 212 
In this study, we demonstrated that C. difficile is widely distributed in soils samples 213 
from both children’s and dog’s sandboxes located within the metropolitanean area of 214 
Madrid. Furthermore, our results revealed that recovered isolates were genetically diverse 215 
and displayed resistance to several antibiotics (≥2 drugs, including in all cases imipenem 216 
and levofloxacin). Notably, analysis of AFLP fingerprinting results showed high genetic 217 
variation even among isolates obtained from a same sampling (sub)zone. 218 
Most C. difficile isolates recovered in this study from sandboxes belonged to 219 
ribotypes 014 and 009. The toxigenic ribotype 014 is one of the most prevalent genotypes 220 
isolated from human patients and animals in Europe (including Spain) and other countries 221 
such as Australia, Brazil and the USA (Bauer et al., 2011; Koene et al. 2012; Alcalá et al. 222 
2012, 2015; Janezic et al., 2012, 2014; Tickler et al., 2014; Freeman et al., 2015; Knight et 223 
al., 2015a,b; Silva et al. 2015). Non-toxigenic ribotype 009 is also prevalent in both human 224 
and animal hosts in some countries including Brazil (Silva et al. 2015), but it is rarely 225 
reported in Spain and the rest of Europe (e.g. Koene et al. 2012; Wetterwik et al., 2013; 226 
Álvarez-Pérez et al., 2015). 227 
Other ribotypes found in this study such as 039 and 106 are also frequently isolated 228 
from human and/or animal fecal samples (Bauer et al., 2011; Alcalá et al., 2012, 2015; 229 
Koene et al., 2012; Tickler et al., 2014; Freeman, 2015). In particular, ribotype 106 has 230 
been implicated in outbreaks of human disease in the UK (Ratnayake et al., 2011) and is 231 
also relatively common in continental Europe and North America (Bauer et al., 2011; 232 
Alcalá et al., 2012, 2015; Tickler et al., 2014; Freeman et al., 2015). We recently obtained 233 
several ribotype 106 isolates from the feces of dogs with diverse digestive disorders (Orden 234 
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et al., 2017). Curiously, despite the frequent shedding of C. difficile ribotype 078 by 235 
animals previously observed in Spain (Peláez et al., 2013; Álvarez-Pérez et al., 2013, 2014, 236 
2015) and many other countries (Janezic et al., 2014) we did not found any isolate of this 237 
epidemic ribotype in the present study. Nevertheless, as a single C. difficile isolate from 238 
each primary culture was selected for detailed phenotypic and genetic characterization, we 239 
cannot discard the possibility that this and other ribotypes might have been overlooked. 240 
Finally, all isolates characterized in this study displayed high-level in vitro 241 
resistance to imipenem and levofloxacin, a phenotype which is fairly common among 242 
diverse ribotypes of C. difficile from different geographic locations (Alcalá et al., 2012; 243 
Keessen et al., 2013; Pirš et al., 2013; Freeman et al., 2015). As carbapenems and 244 
fluoroquinolones are widely used in human and veterinary medicine to treat a diversity of 245 
infections (Papich, 2011; Papp-Wallace et al., 2011; Redgrave et al., 2014), monitoring the 246 
resistance to these compounds in C. difficile and other emerging pathogens should be a 247 
priority. Furthermore, some isolates were found to be resistant to erythromycin, 248 
clindamycin and penicillin G, all of which are of common use in clinical practice (Papich, 249 
2011). Although we did not detect any isolate with decreased susceptibility or 250 
heterogeneous resistance to metronidazole, we recommend to determine MIC values to this 251 
antibiotic even for environmental isolates, as metronidazole is still considered a first-line 252 
drug for the treatment of anaerobe infections in human and animal medicine (Dhand and 253 
Snydman, 2009; Löfmark et al., 2010; Papich, 2016) and (hetero)resistant strains of C. 254 
difficile and other clostridia have been reported by different authors (Peláez et al., 2008, 255 
2013; Álvarez-Pérez et al., 2013, 2014, 2015, 2017; Wetterwik et al., 2013). 256 
 257 
Conclusions 258 
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In summary, our results revealed the presence of epidemic ribotypes of C. difficile in 259 
children’s and dog’s sandboxes, which constitutes a major health risk. Due to the zoonotic 260 
potential attributed to some ribotypes of C. difficile, the possible presence of this emerging 261 
pathogen should be considered in any environmental risk assessment. 262 
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Figure Legends 441 
Figure 1. Dendrogram of AFLP profiles obtained for the 20 Clostridium difficile isolates 442 
characterized in this study. The dendrogram was created by unweighted pair group method 443 
with arithmetic averages (UPGMA) clustering using Pearson’s correlation coefficients. 444 
Individual AFLP genotypes are distinguished at ≥86% similarity (red dotted vertical line). 445 
Isolates obtained from children’s and dog’s sandboxes are indicated by blue and yellow 446 
backgrounds, respectively. Colored squares at the tip of branches indicate the ribotype (see 447 
color legend on the lower left corner). In vitro resistance to clindamycin (C), erythromycin 448 
(E), imipenem (I), levofloxacin (L) and/or penicillin G (P) is denoted by the red letters next 449 
to strain names.  450 
Figure 2. Image showing the children’s and dog’s sandboxes from zone V which yielded 451 
ribotype 014 Clostridium difficile isolates (see details in Results). 452 
 453 
454 
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Supporting Information 455 
Additional Supporting Information may be found in the online version of this article: 456 
Table S1. Characteristics of the Clostridium difficile isolates analyzed in this study. 457 
Figure S1. Schematic representation of the Madrid region (central Spain), indicating the 458 
approximate location of the zones from which sand samples were obtained in this study. 459 
 460 
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 Impacts 21 
• The sand of public playgrounds can have a role in the transmission of various 22 
infections, particularly in children. However, most studies published so far have 23 
focused on select pathogenic parasites and fecal bacteria. 24 
• In this study we demonstrated that the Gram-positive anaerobe Clostridium difficile is 25 
widely distributed in soils samples from children’s and dog’s sandboxes located within 26 
the metropolitanean area of Madrid. 27 
• Furthermore, we demonstrated the presence of genetically diverse strains of C. difficile, 28 
including the epidemic PCR ribotypes 014 and 106, in the studied sandboxes. 29 
30 
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Different studies have suggested that the sand of public playgrounds could have a role in 32 
the transmission of infections, particularly in children. Furthermore, free access of pets and 33 
other animals to the playgrounds might increase such a risk. We studied the presence of 34 
Clostridium difficile in 20 pairs of sandboxes for children and dogs located in different 35 
playgrounds within the Madrid region (Spain). C. difficile isolation was performed 36 
according to standardby enrichment and selective culture procedures. The genetic (ribotype 37 
and amplified fragment length polymorphism [AFLP]) diversity and antibiotic 38 
susceptibility of isolates was also studied. Overall, 52.5% (21/40) of samples were positive 39 
for the presence of C. difficile. Eight of the 20 available isolates belonged to the toxigenic 40 
ribotypes 014 (n = 5) and 106 (n = 2), both regarded as epidemic, and CD047 (n = 1). The 41 
other 12 isolates were non-toxigenic, and belonged to ribotypes 009 (n = 5), 039 (n = 4), 42 
and 067, 151 and CD048 (one isolate each). Nevertheless, all isolates (even those of a same 43 
ribotype) were classified into different AFLP genotypes indicating non-relatedness. In 44 
conclusion, our results revealed the presence of epidemic ribotypes of C. difficile in 45 
children’s and dog’s sandboxes located nearby, which constitutes a major health risk. 46 
 47 
Keywords: Clostridium difficile; children; dog; epidemic strains; sandboxes. 48 
49 
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The soil of playgrounds is a reservoir of diverse parasites and infectious agents (Martínez-51 
Moreno et al., 2007; Dado et al., 2012; Gotkowska-Płachta and Korzeniewska, 2014; Staley 52 
et al., 2016). Furthermore, free access of domestic and wild animals to recreational areas 53 
can increase the burden of microbiological contamination (Haag-Wackernagel and Moch, 54 
2004; Martínez-Moreno et al., 2007; Dado et al., 2012; Gotkowska-Płachta and 55 
Korzeniewska, 2014; Staley et al., 2016). Children are generally regarded as the main 56 
group at risk for environmental exposure to pathogens, not only because they are frequent 57 
users of playgrounds, but also due to the high prevalence of geophagia (i.e. consumption of 58 
sand) within this group, and the immaturity of their immunological, neurological and 59 
digestive systems (Nwachuku and Gerba, 2004; Dado et al., 2012; Gotkowska-Płachta and 60 
Korzeniewska, 2014). 61 
Clostridium difficile is a Gram-positive, anaerobic bacterium of widespread 62 
distribution in the environment, where it can survive under adverse conditions through the 63 
production of spores (Hensgens et al., 2012; Smits et al., 2016). This bacterial species was 64 
traditionally regarded as a primarily nosocomial pathogen, but this view has been 65 
challenged as the incidence of C. difficile infection (CDI) in people outside hospitals started 66 
to increase (Hensgens et al., 2012; Smits et al., 2016). In this context, diverse animal 67 
species, food products and environmental sources have been suggested to play a role in the 68 
transmission of the C. difficile and, in particular, of some epidemic genotypes such as 69 
ribotype 078 (Hensgens et al., 2012; Smits et al., 2016). However, to the best of our 70 
knowledge, the presence of C. difficile in sandboxes of playgrounds has only been explored 71 
in a limited number of studies (al Saif and Brazier, 1996; Higazi et al. 2011; Båverud et al., 72 
2003). 73 
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In this study we determined the presence of C. difficile in 20 pairs of recreational 74 
sandboxes for children and dogs located in different playgrounds within the Madrid region 75 
(Spain). In addition, we compared the isolates recovered from children’s and dog’s 76 
sandboxes in terms of genetic characteristics and in vitro antimicrobial susceptibility. 77 
 78 
Materials and methods 79 
Sampling scheme 80 
Sampling was carried out on two consecutive days (July 1-2, 2015) in 20 pairs of children’s 81 
and dog’s sandboxes located nearby (within 94 m in all cases, mean ± S.D. = 35.1 ± 20.5 82 
m; Table 1) in public playgrounds scattered throughout three zones (A, M and V; postal 83 
codes: E-28047, E-28222/E-28221/E-28220 and E-28400, respectively) within the Madrid 84 
region (central Spain) (Figure S1). Therefore, a total of 40 sandboxes (20 for children and 85 
20 for dogs) were analyzed. The number and distribution of samples per sampling zone and 86 
sampling point is indicated in Table 1. 87 
A 200-g sand sample was obtained from each sampling point according to the 88 
procedure described in Córdoba et al. (2002). Briefly, four 50-g sand samples were 89 
collected from different locations within the sampling point using a sterile plastic container 90 
(Nirco, Madrid, Spain). All four sand samples were then thoroughly mixed in a sterile 91 
plastic bag (Nirco), which was transported to the laboratory and kept frozen (-20ºC) until 92 
analyzed, which took place within 24 h. 93 
94 
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Microbiological analyses 95 
Sand samples (50 g each, taken and aseptically weighted from the 200-g mixtures kept in 96 
the freezer) were transferred into sterile one-liter glass bottles, diluted 1:10 in peptone 97 
water (Laboratorios Conda, Madrid. Spain) and incubated under agitation (200 rpm) for 15 98 
min at room temperature. These suspensions were then allowed to settle for 5 min and the 99 
supernatants were filtered though filter papers membranes (0.45 µm of pore size; Filter Lab, 100 
Barcelona, Spain) following the procedure detailed in Álvarez-Pérez et al. (2016). Filter 101 
papers membranes were then introduced into 10-ml glass tubes containing 5 ml of selective 102 
broth for enrichment of C. difficile (TecLaim, Madrid, Spain; see recipe in Blanco et al., 103 
2013). After seven days of incubation at 37°C under anaerobiosis, 2 ml of the enrichment 104 
culture were mixed 1:1 with absolute ethanol (Panreac, Barcelona, Spain) in 5 ml sterile 105 
plastic tubes (Nirco, Madrid, Spain) and left for 1 hour under agitation (200 rpm) at room 106 
temperature. Finally, tubes were centrifuged at 1520 g for 10 min, the supernatants were 107 
discarded and precipitates were spread with a sterile cotton-tipped swab (Nirco) onto a 108 
plate of CLO agar (bioMérieux, Marcy l’Etoile, France), which contains cycloserine and 109 
cefoxitin as selective agents. Inoculated plates were incubated under anaerobic conditions 110 
for 72 h at 37°C and suspected colonies were identified as C. difficile by colony 111 
morphology, the typical odor of this microorganism, and a positive result in a rapid specific 112 
immunoassay for detection of the constitutive antigen glutamate dehydrogenase (GDH) (C. 113 
Diff Quik Chek Complete; TECHLAB Inc., Blacksburg, VA, USA). The same 114 
immunoassay was used to determine the toxigenic/non toxigenic status of isolates, as it 115 
detects production of C. difficile toxins A and B. A single C. difficile isolate was selected 116 
from each primary culture and sub-cultured on CLO agar to obtain axenic cultures that 117 
could be used in subsequent tests. 118 
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Molecular characterization of isolates 120 
Possession of tcdA and tcdB genes (which encode for toxins A and B, respectively), and 121 
cdtA and cdtB (which encode for the two components of binary toxin (CDT), respectively), 122 
was analyzed by conventional PCR protocols (Álvarez-Pérez et al. 2009, 2014, 2015). 123 
Genotyping of isolates was performed by high-resolution capillary gel-based 124 
electrophoresis PCR-ribotyping, following the procedures described in Fawley et al. 125 
(2015). Ribotypes were designated according to the nomenclature of the Leiden (Prof. Ed 126 
Kuijper; The Netherlands)-Leeds (Dr. Warren Fawley and Prof. Mark Wilcox; UK) 127 
database (The Netherlands). If a matching PCR ribotype was not found, the electrophoresis 128 
profile was sent to Leeds for a search in the Leeds database of more than 600 PCR 129 
ribotypes (Dr. Warren Fawley and Prof. Mark Wilcox, Leeds).Novel ribotypes were named 130 
using internal reference codes (prefix ‘CD’ followed by a number). 131 
Isolates were further genetically characterized by amplified fragment length 132 
polynorphism (AFLP) fingerprinting, using the protocol detailed in Álvarez-Pérez et al. 133 
(2017). A binary 0/1 matrix was created based on the absence/presence of AFLP markers 134 
and a dendrogram of AFLP patterns was created with PAST v.3.11 software (Hammer et 135 
al., 2001) using Pearson’s correlation coefficients and the unweighted-pair group method 136 
with arithmetic averages (UPGMA) clustering algorithm. Isolates clustering with <86% 137 
similarity were considered to represent different AFLP genotypes (Killgore et al., 2008; 138 
Álvarez-Pérez et al., 2017). 139 
 140 
Antimicrobial susceptibility testing 141 
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In vitro susceptibility of isolates was determined by the Etest (bioMérieux) on prereduced 142 
Brucella agar supplemented with vitamin K1 and haemin (bioMérieux), according to the 143 
manufacturer’s instructions. Plates were incubated anaerobically at 37°C and examined at 144 
48 h. Tested antimicrobial compounds and breakpoints for antimicrobial resistance were as 145 
follows: penicillin G, ≥2 µg/ml; teicoplanin, >2 µg/ml; rifampicin, ≥4 µg/ml; linezolid and 146 
tigecycline, >4 µg/ml; clindamycin, erythromycin and levofloxacin, ≥8 µg/ml; imipenem, 147 
minocycline and tetracycline, ≥16 µg/ml; amoxicillin/clavulanic acid, ≥16/8 µg/ml; and 148 
metronidazole and vancomycin, ≥32 µg/ml. (CLSI, 2012; Álvarez-Pérez et al., 2013, 2014, 149 
2015, 2017; Peláez et al. 2013). 150 
In order to detect possible metronidazole heteroresistance, which is manifested as a 151 
slow growth of resistant subpopulations within the inhibition halo in the Etest at 152 
concentrations above the resistance breakpoint, metronidazole test plates were further 153 
incubated anaerobically at 37°C for five additional days (Peláez et al., 2008). 154 
 155 
Data analysis 156 
Fisher’s exact test and Pearson’s chi-square test were used for statistical analysis of 157 
categorical data where appropriate. P-values of <0.05 were considered to be statistically 158 
significant in all cases. 159 
 160 
Results 161 
Clostridium difficile was recovered from 21 (52.5%) of the sand samples analyzed, 162 
collected from 12 and 9 sandboxes located in recreational areas for dogs and children, 163 
respectively (Table 1). The distribution of isolates by sampling (sub)zone and type of 164 
sample (children’s or dog’s sandboxes) is shown in Table 1. There was no difference in C. 165 
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difficile prevalence between children’s and dog’s sandboxes (P = 0.527) or among 166 
sampling zones (P = 0.203). A positive culture result for both samples of each pair was 167 
obtained in five cases, whereas C. difficile was recovered only from one sandbox of the pair 168 
in 11 cases (four from children’s sandboxes and seven from dog’s sandboxes) and a 169 
negative culture result for both samples was obtained in four cases (Table 1). 170 
One C. difficile isolate (obtained from a children’s sandbox in zone A [sample A-N-171 
2], Table 1) was lost during subculturing in the laboratory. Eight of the 20 remaining 172 
isolates (seven six from dog’s and four two from children’s sandboxes) were toxigenic and 173 
belonged to ribotypes 014 (A+B+CDT-, n = 5), 106 (A+B+CDT-, n = 2) and CD047 (isolate 174 
M-P-4, A+B+CDT-) (Tables 1 and S1, Figure 1). The other eight 12 isolates were non-175 
toxigenic (i.e. A-B-CDT-) and belonged to ribotypes 009 (n = 5), 039 (n = 4), and 067, 151 176 
and CD048 (one isolate each) (Tables 1 and S1, Figure 1). Further genetic characterization 177 
of isolates by AFLP fingerprinting classified each one of these into a different genotype 178 
(Figure 1 and Table S1). Notably, clustering of isolates in the UPGMA dendrogram 179 
obtained from AFLP data was independent from the origin (both at the ‘(sub)zone’ and 180 
‘children vs. dog areas’ levels) and ribotype of isolates (Figure 1). 181 
Regardless of their origin and genotype, all studied isolates showed resistance to 182 
imipenem and levofloxacin (Figure 1 and Table S1). Additionally, the isolates of ribotypes 183 
CD048 and 151 (A-N-8 and V-N-1, respectively) displayed  resistance to clindamycin and 184 
erythromycin, and a ribotype 014 isolate (A-P-3) was resistant to penicillin (Figure 1 and 185 
Table S1). MICs to the other antimicrobial compound tested were generally low, and fell 186 
below the resistance breakpoint in all cases (Table S1). 187 
Notably, the samples obtained from a pair of children’s and dog’s sandboxes in zone 188 
V (V-N-2/V-P-2; Figure 2) yielded C. difficile isolates of a same toxigenic ribotype (014) 189 
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and which showed a similar antimicrobial susceptibility profile, but the AFLP profiles of 190 
such isolates displayed limited similarity (Pearson’s correlation = 0.126) (Figure 1). In 191 
contrast, four pairs of sand samples (A-N-3/A-P-3, A-N-4/A-P-4, A-N-5/A-P-5 and V-N-192 
1/V-P-1) yielded C. difficile isolates of different ribotypes. 193 
 194 
Discussion 195 
The growing number of pets and other animals leaving excrements in the sandboxes of 196 
playgrounds and other recreational areas constitute a serious epidemiological threat 197 
(Martínez-Moreno et al., 2007; Gotkowska-Płachta and Korzeniewska, 2014; Staley et al., 198 
2016). Current tests for assessing the sanitary conditions of sandboxes mostly focus on 199 
detecting some select pathogenic parasites and bacterial indicators of fecal contamination 200 
(Martínez-Moreno et al., 2007; Gotkowska-Płachta and Korzeniewska, 2014; Staley et al., 201 
2016), but mostly neglect the possible presence of other emerging pathogens such as C. 202 
difficile. 203 
Reports of C. difficile presence in recreational sandboxes are still limited in number 204 
and of variable scope. For example, Al-Saif and Brazier (1996) reported the isolation of C. 205 
difficile from a 21% of soil samples taken from public parks, gardens, playgrounds and 206 
other locations in the suburbs of Cardiff, UK. Subsequent characterization of some of those 207 
soil isolates by PCR ribotyping and pyrolysis mass spectrometry (PyMS) fingerprinting 208 
revealed the presence of toxin-producers and different ribotypes (Al Saif et al., 1998). 209 
Similarly, Higazi et al. (2011) investigated by a PCR-based approach the presence of C. 210 
difficile in soil samples from public parks and elementary school playgrounds in a 211 
Midwestern town of the USA and reported an overall prevalence of 6.5%, but bacterial 212 
isolates were only obtained in some cases and these were not genotyped nor tested for 213 
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antimicrobial resistance. Finally, Båverud et al. (2013) observed an overall C. difficile 214 
prevalence of 4% in soil samples obtained from public parks, playgrounds, gardens and 215 
cultivated fields, but the origin and characteristics of recovered isolates were not detailed in 216 
their paper. 217 
In this study, we demonstrated that C. difficile is widely distributed in soils samples 218 
from both children’s and dog’s sandboxes located within the metropolitanean area of 219 
Madrid. Furthermore, our results revealed that recovered isolates were genetically diverse 220 
and displayed resistance to several antibiotics (≥2 drugs, including in all cases imipenem 221 
and levofloxacin). Notably, analysis of AFLP fingerprinting results showed high genetic 222 
variation even among isolates obtained from a same sampling (sub)zone. 223 
Most C. difficile isolates recovered in this study from sandboxes belonged to 224 
ribotypes 014 and 009. The toxigenic ribotype 014 is one of the most prevalent genotypes 225 
isolated from human patients and animals in Europe (including Spain) and other countries 226 
such as Australia, Brazil and the USA (Bauer et al., 2011; Koene et al. 2012; Alcalá et al. 227 
2012, 2015; Janezic et al., 2012, 2014; Tickler et al., 2014; Freeman et al., 2015; Knight et 228 
al., 2015a,b; Silva et al. 2015). Non-toxigenic ribotype 009 is also prevalent in both human 229 
and animal hosts in some countries including Brazil (Silva et al. 2015), but it is rarely 230 
reported in Spain and the rest of Europe (e.g. Koene et al. 2012; Wetterwik et al., 2013; 231 
Álvarez-Pérez et al., 2015). 232 
Other ribotypes found in this study such as 039 and 106 are also frequently isolated 233 
from human and/or animal fecal samples (Bauer et al., 2011; Alcalá et al., 2012, 2015; 234 
Koene et al., 2012; Tickler et al., 2014; Freeman, 2015). In particular, ribotype 106 has 235 
been implicated in outbreaks of human disease in the UK (Ratnayake et al., 2011) and is 236 
also relatively common in continental Europe and North America (Bauer et al., 2011; 237 
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Alcalá et al., 2012, 2015; Tickler et al., 2014; Freeman et al., 2015). We recently obtained 238 
several ribotype 106 isolates from the feces of dogs with diverse digestive disorders (Orden 239 
et al., 2017). Curiously, despite the frequent shedding of C. difficile ribotype 078 by 240 
animals previously observed in Spain (Peláez et al., 2013; Álvarez-Pérez et al., 2013, 2014, 241 
2015) and many other countries (Janezic et al., 2014) we did not found any isolate of this 242 
epidemic ribotype in the present study. Nevertheless, as a single C. difficile isolate from 243 
each primary culture was selected from each primary culture for detailed phenotypic and 244 
genetic characterization, we cannot discard the possibility that this and other ribotypes 245 
might have been overlooked. 246 
Finally, all isolates characterized in this study displayed high-level Iin vitro 247 
resistance to imipenem and levofloxacin, a phenotype which  is fairly common among 248 
clinical C. difficile isolates of diverse ribotypes of C. difficile from different geographic 249 
locations (Alcalá et al., 2012; Keessen et al., 2013; Pirš et al., 2013; Freeman et al., 2015). 250 
As  carbapenems and fluoroquinolones are widely used in human and veterinary medicine 251 
to treat a diversity of infections (Papich, 2011; Papp-Wallace et al., 2011; Redgrave et al., 252 
2014), monitoring the resistance to these compounds in C. difficile and other emerging 253 
pathogens should be a priority. Furthermore, some isolates were found to be resistant to 254 
erythromycin, clindamycin and penicillin G, all of which are of common use in clinical 255 
practice (Papich, 2011). Although we did not detect any isolate with decreased 256 
susceptibility or heterogeneous resistance to metronidazole, we recommend to determine 257 
MIC values to this antibiotic even for environmental isolates, as metronidazole is still 258 
considered a first-line drug for the treatment of anaerobe infections in human and animal 259 
medicine (Dhand and Snydman, 2009; Löfmark et al., 2010; Papich, 2016) and 260 
(hetero)resistant strains of C. difficile and other clostridia have been reported by different 261 
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authors (Peláez et al., 2008, 2013; Álvarez-Pérez et al., 2013, 2014, 2015, 2017; Wetterwik 262 
et al., 2013). 263 
 264 
Conclusions 265 
In summary, our results revealed the presence of epidemic ribotypes of C. difficile in 266 
children’s and dog’s sandboxes, which constitutes a major health risk. Due to the zoonotic 267 
potential attributed to some ribotypes of C. difficile, the possible presence of this emerging 268 
pathogen should be considered in any environmental risk assessment. 269 
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Figure Legends 449 
Figure 1. Dendrogram of AFLP profiles obtained for the 20 Clostridium difficile isolates 450 
characterized in this study. The dendrogram was created by unweighted pair group method 451 
with arithmetic averages (UPGMA) clustering using Pearson’s correlation coefficients. 452 
Individual AFLP genotypes are distinguished at ≥86% similarity (red dotted vertical line). 453 
Isolates obtained from children’s and dog’s sandboxes are indicated by blue and yellow 454 
backgrounds, respectively. Colored squares at the tip of branches indicate the ribotype (see 455 
color legend on the lower left corner). In vitro resistance to clindamycin (C), erythromycin 456 
(E), imipenem (I), levofloxacin (L) and/or penicillin G (P) is denoted by the red letters next 457 
to strain names.  458 
Figure 2. Image showing the children’s and dog’s sandboxes from zone V which yielded 459 
ribotype 014 Clostridium difficile isolates (see details in Results). 460 
 461 
462 
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Supporting Information 463 
Additional Supporting Information may be found in the online version of this article: 464 
Table S1. Characteristics of the Clostridium difficile isolates analyzed in this study. 465 
Figure S1. Schematic representation of the Madrid region (central Spain), indicating the 466 
approximate location of the zones from which sand samples were obtained in this study. 467 
 468 
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* ND: not determined (this isolates was lost during subculturing in the laboratory). 2 
† Distance between the children’s and dog’s sandboxes of each sampling point. 3 
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Dendrogram of AFLP profiles obtained for the 20 Clostridium difficile isolates characterized in this study. The 
dendrogram was created by unweighted pair group method with arithmetic averages (UPGMA) clustering 
using Pearson’s correlation coefficients. Individual AFLP genotypes are distinguished at ≥86% similarity (red 
dotted vertical line). Colored squares at the tip of branches indicate the ribotype (see color legend on the 
lower left corner). In vitro resistance to clindamycin (C), erythromycin (E), imipenem (I), levofloxacin (L) 
and/or penicillin G (P) is denoted by the red letters next to strain names.  
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Image showing the children’s and dog’s sandboxes from zone V which yielded ribotype 014 Clostridium 
difficile isolates (see details in Results).  
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